According to our Turkish cohort of 191 patients with biologically high-risk breast cancer following NACT, we found evidence of obesity as an independently negative predictive factor of achieving pCR, especially in postmenopausal and HR-positive/HER2-negative patients. Here, ERBB2 is linked to obesity due to melanocortin 4 receptor deficiency.